Photocure ASA
0IMT.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.31B
Close$
$56.24
13.6% upside
Current Fair Value
13.6% upsideUndervalued by 13.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.31 Billion |
|---|---|
| Enterprise Value | $1.16 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.06 |
| Beta | 0.35 |
| Outstanding Shares | 26,916,610 |
Return
| Return on Equity | 12.98% |
|---|---|
| Return on Assets | 8.74% |
| Return on Invested Capital | 24.71% |
Valuation & Multiples
| P/E Ratio | 16.67 |
|---|---|
| PEG | -14.55 |
| Price to Sales | 1.98 |
| Price to Book Ratio | 2.25 |
| Enterprise Value to Revenue | 1.71 |
| Enterprise Value to EBIT | 5.87 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 29, 2026
EPS Estimate
$0.02
Average shareholder expectationRevenue Estimate
$141.60 M
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$144.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Photocure ASA
101 employees
CEO: Daniel Schneider Photocure ASA operates as a specialized pharmaceutical company, managing the entire lifecycle of pharmaceutical products from initial research and development through to their manufacturing, distribution, marketing, and commercialization...